Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 2 hours 51 min ago

Upstart Publishes June 2026 Origination Volume

Mon, 07/06/2026 - 09:05
BURLINGAME, Calif.--(BUSINESS WIRE)--Upstart Publishes June 2026 Origination Volume

Walker & Dunlop Arranges $232 Million Financing for Workforce Housing Portfolio

Mon, 07/06/2026 - 09:05
BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop arranged $232,352,000 in financing for a portfolio of five multifamily properties totaling 1,585 units across Arkansas and Florida.

Skillsoft Completes Sale of Global Knowledge Business, Advancing Focus on AI-Native Skills Management Platform

Mon, 07/06/2026 - 09:05
BOSTON--(BUSINESS WIRE)--Skillsoft (NYSE: SKIL), a leading AI-native skills management platform, today announced that it has completed the sale of its Global Knowledge business to an affiliate of Enduring Ventures. With the transaction complete, Skillsoft has a simplified portfolio focused entirely on its AI-native skills management platform. As AI changes which skills matter and how quickly they evolve, Skillsoft helps organizations track that shift and act on it. Skillsoft expects to maintain

Unum Group Announces $3.8 Billion Long-Term Care Reinsurance Transaction with Fortitude Re

Mon, 07/06/2026 - 06:05
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--Unum Group (NYSE: UNM) announced today that its Unum Life Insurance Company of America subsidiary (“Unum America”) has entered into an agreement to cede to Fortitude Reinsurance Company Ltd. (“Fortitude Re”), on a coinsurance basis, certain individual long-term care (“LTC”) insurance policies representing $3.8 billion of statutory reserves in Fairwind Insurance Company, a wholly owned subsidiary of Unum (“Fairwind”). At closing, Unum America will recapture t

Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis

Mon, 07/06/2026 - 03:05
PARIS & LONDON--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to $1.5 billion including $1.1 billion cash upfront plus potential milestone payments. This marks Sofinnova Partners' seventh exit in three years. Myricx Bio is a UK-headquartered transatlantic biotech company focused on the discovery and development of a novel class o

Pages